These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25206257)

  • 1. Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?
    Principi M; Barone M; Pricci M; De Tullio N; Losurdo G; Ierardi E; Di Leo A
    World J Gastroenterol; 2014 Sep; 20(33):11496-504. PubMed ID: 25206257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcerative colitis-associated colorectal cancer.
    Yashiro M
    World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence.
    Bezzio C; Festa S; Saibeni S; Papi C
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):339-347. PubMed ID: 28165825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma.
    Principi M; Scavo MP; Piscitelli D; Villanacci V; Lovero R; Losurdo G; Girardi B; Ierardi E; Di Leo A
    Scand J Gastroenterol; 2015 Aug; 50(8):1002-10. PubMed ID: 25862314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors and chemoprophylaxis of ulcerative colitis-colorectal cancer].
    Pang S; Zong Y; Wu YD
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Nov; 56(11):1657-1662. PubMed ID: 36372759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta as target for colorectal cancer prevention.
    Williams C; DiLeo A; Niv Y; Gustafsson JÅ
    Cancer Lett; 2016 Mar; 372(1):48-56. PubMed ID: 26708506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic ulcerative colitis and colorectal cancer.
    Rogler G
    Cancer Lett; 2014 Apr; 345(2):235-41. PubMed ID: 23941831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colorectal cancer in ulcerative colitis.
    Croog VJ; Ullman TA; Itzkowitz SH
    Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
    Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
    Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention.
    Li W; Zhao T; Wu D; Li J; Wang M; Sun Y; Hou S
    Curr Oncol; 2022 Aug; 29(9):6091-6114. PubMed ID: 36135048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.
    Fajardo AM; Piazza GA
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G59-70. PubMed ID: 26021807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
    Yu LZ; Wang HY; Yang SP; Yuan ZP; Xu FY; Sun C; Shi RH
    World J Gastroenterol; 2013 May; 19(17):2638-49. PubMed ID: 23674871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
    Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
    Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models.
    Seril DN; Liao J; Yang GY; Yang CS
    Carcinogenesis; 2003 Mar; 24(3):353-62. PubMed ID: 12663492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary, endocrine, and metabolic factors in the development of colorectal cancer.
    Barone M; Lofano K; De Tullio N; Licinio R; Albano F; Di Leo A
    J Gastrointest Cancer; 2012 Mar; 43(1):13-9. PubMed ID: 22045273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Anti-tumour Necrosis Factor Agents on the Risk of Colorectal Cancer in Patients with Ulcerative Colitis: Nationwide French Cohort Study.
    Charkaoui M; Hajage D; Tubach F; Beaugerie L; Kirchgesner J
    J Crohns Colitis; 2022 Jul; 16(6):893-899. PubMed ID: 34657962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.